UMIN ID: C000000142
Registered date:08/09/2005
PhaseII stady of gefitinib and in patients with relapsed advanced non-small cell lung cancer
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | relapsed advanced non-small cell lung cartinoma |
| Date of first enrollment | 2004/02/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Patients receive oral gefitinib 250mg and meloxicam 10mg once daily |
Outcome(s)
| Primary Outcome | Response rate |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1)Uncontrolled infection, cardiac disease, hepatic disease, and so on (2)Evidence of interstitial lung disease in chest x-p (3)Active brain metastases (4)Other active malignancy (5)History of bone marrow transplantation (6)History of peripheral blood stem cell transplantation (7)Allergy to any drugs (8)Pregnant or nursing women (9)Patients don't have will of contraception (10)Uncontrolled diabetes (11)Other concurrent serious medical condition |
Related Information
| Primary Sponsor | Department of Medical Oncology Kinki University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Medical Oncology Kinki University School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | 072-366-0221 |
| Affiliation | Kinki University School of Medicine Department of Medical Oncology |
| scientific contact | |
| Name | Asuka Tsuya |
| Address | 377-2, Ohno-Higashi, Osakasayama city, Osaka, Japan Japan |
| Telephone | |
| Affiliation | Kinki University School of Medicine Department of Medical Oncology |